Xeris Biopharma Holdings, Inc.XERSNASDAQ
LOADING
|||
Revenue Scaling
Trending higher, above historical average, strong compound growth.
Left:
||||
Total revenue from sales of goods and services
Latest
$203.07M
↑ 229% above average
Average (8y)
$61.67M
Historical baseline
Range
High:$203.07M
Low:$1.07M
CAGR
+92.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $203.07M | +23.9% |
| 2023 | $163.91M | +48.7% |
| 2022 | $110.25M | +122.3% |
| 2021 | $49.59M | +142.7% |
| 2020 | $20.43M | +650.7% |
| 2019 | $2.72M | +10.4% |
| 2018 | $2.46M | +58.4% |
| 2017 | $1.56M | +44.7% |
| 2016 | $1.07M | - |